Lv2
200 积分 2024-07-16 加入
Atorvastatin in Severity-Stratified Pulmonary Sarcoidosis: A Phase II Randomized Controlled Trial
2天前
已完结
Predictive role of natural killer cells in bronchoalveolar lavage fluid of patients with sarcoidosis
2天前
已完结
Predictive role of natural killer cells in bronchoalveolar lavage fluid of patients with sarcoidosis
2天前
已关闭
External validation of the 2017 EULAR/ACR classification criteria for idiopathic inflammatory myopathies in anti-MDA5 antibody-positive interstitial lung disease patients: A multicenter retrospective cohort study in China
26天前
已完结
Tacrolimus as first line therapy in a U.S. cohort of idiopathic inflammatory myopathies related interstitial lung disease
1个月前
已关闭
Effectiveness and safety of tofacitinib versus calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multi-centre cohort study
1个月前
已完结
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients
1个月前
已关闭
Prognostic Value of Main Pulmonary Artery Diameter in Pulmonary Arterial Hypertension
1个月前
已完结
High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial)
4个月前
已完结
Sarcoidosis
6个月前
已完结
皖公网安备34019202002308
